United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
1997_register
executive
2010-09-24
article
Implementation of Emergency Research Informed Consent Waiver Rule; Public Meeting
Rules and Regulations
D09002ee1be013001
D09002ee1be013087
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
Food and Drug Administration
originator
org
United States Government Agency or Subagency
The Food and Drug Administration (FDA) is announcing a public meeting on the implementation of a final rule that defined conditions for an exception to the normal requirements for obtaining informed consent from persons participating as subjects in research. FDA is holding the public meeting because some parties interested in research conducted under the final rule have expressed to FDA a need for additional information on acceptable implementation procedures. The purpose of this public meeting is to provide an open discussion of the issues involved in implementing the requirements of the rule. DATES: The public meeting will be held on September 29 and 30, 1997. On September 29, 1997, the meeting will be from 9:30 a.m. to approximately 5:30 p.m. On September 30, 1997, the meeting will be from 8 a.m. to approximately 11:45 a.m. Registration is recommended by September 19, 1997. Opportunity for public participation will be provided during both days of the meeting. Written comments will be accepted until October 31, 1997.
62 FR 46198
https://www.govinfo.gov/app/details/FR-1997-09-02/97-23123
97-23123
fr02se97-9
4160-01-F
Docket No. 97N-0342
https://www.govinfo.gov/app/details/FR-1997-09-02/97-23123
https://www.govinfo.gov/content/pkg/FR-1997-09-02/html/97-23123.htm
https://www.govinfo.gov/content/pkg/FR-1997-09-02/pdf/97-23123.pdf
2 p.
46198
46199
62 FR 46198
Code of Federal Regulations
Title 21 Part 312
21 CFR Part 312
Code of Federal Regulations
Title 21 Part 314
21 CFR Part 314
Code of Federal Regulations
Title 21 Part 50
21 CFR Part 50
Code of Federal Regulations
Title 21 Part 56
21 CFR Part 56
Code of Federal Regulations
Title 21 Part 601
21 CFR Part 601
Code of Federal Regulations
Title 21 Part 812
21 CFR Part 812
Code of Federal Regulations
Title 21 Part 814
21 CFR Part 814
Implementation of Emergency Research Informed Consent Waiver Rule; Public Meeting; Federal Register Vol. 62, Issue
RULE
97-23123
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
1997-10-31
1997-09-29
Docket No. 97N-0342
4160-01-F
97-23123
Notification of a public meeting.
The Food and Drug Administration (FDA) is announcing a public meeting on the implementation of a final rule that defined conditions for an exception to the normal requirements for obtaining informed consent from persons participating as subjects in research. FDA is holding the public meeting because some parties interested in research conducted under the final rule have expressed to FDA a need for additional information on acceptable implementation procedures. The purpose of this public meeting is to provide an open discussion of the issues involved in implementing the requirements of the rule. DATES: The public meeting will be held on September 29 and 30, 1997. On September 29, 1997, the meeting will be from 9:30 a.m. to approximately 5:30 p.m. On September 30, 1997, the meeting will be from 8 a.m. to approximately 11:45 a.m. Registration is recommended by September 19, 1997. Opportunity for public participation will be provided during both days of the meeting. Written comments will be accepted until October 31, 1997.
The public meeting will be held on September 29 and 30, 1997. On September 29, 1997, the meeting will be from 9:30 a.m. to approximately 5:30 p.m. On September 30, 1997, the meeting will be from 8 a.m. to approximately 11:45 a.m. Registration is recommended by September 19, 1997. Opportunity for public participation will be provided during both days of the meeting. Written comments will be accepted until October 31, 1997.
Glen D. Drew, Office of Health Affairs (HFY-20), Food and Drug Administration, 5600 Fishers Lane, rm. 15-22, Rockville, MD 20857, 301-443-1382, FAX 301-443-0232.
Federal Register
Vol. 62, no. 169
Office of the Federal Register, National Archives and Records Administration
1997-09-02
continuing
daily
deposited
born digital
267 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-1997-09-02
P0b002ee180a351c6
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr02se97
https://www.govinfo.gov/app/details/FR-1997-09-02
https://www.govinfo.gov/content/pkg/FR-1997-09-02/pdf/FR-1997-09-02.pdf
fdlp
46175
46430
DGPO
2010-09-24
2023-05-06
FR-1997-09-02
machine generated
eng
FR
FR-1997-09-02
62
169